
    
      Study entry examinations:

        -  blood cell count

        -  liver enzymes

        -  ventilatory function test

        -  pregnancy test (premenopausal women)

        -  CT of the thorax

        -  CT of the brain

        -  Ultrasound of the liver

        -  Bone scan

        -  FDG PET scan (after inclusion)

      Follow-up examinations (2 months, than every 3 months):

        -  patients history and examination

        -  CT scan of the thorax

        -  ventilatory functions test

        -  FDG PET scan (at least at 6 months)

        -  bone scan (yearly)

        -  ultrasound of the liver (every 6 months)

      Cetuximab administration:

        -  450 mg / m^2 body surface on week 1

        -  250 mg /m^2 body surface weekly, week 2 -21

      Radiation therapy:

        -  intensity modulated radiation therapy of primary tumor and mediastinum (2 Gy single
           dose, total dose 50 Gy; 5 fractions per week) with boost to the PET positive sites (2 Gy
           single doses up to 66 Gy). Radiation therapy during weeks 2-8.

      Amendment 1/07: 3D conformal RT possible, but not if FeV1 < 1.5L of < 50%
    
  